247 related articles for article (PubMed ID: 34717952)
1. Cluster Analysis of Circulating Plasma Biomarkers in Prurigo Nodularis Reveals a Distinct Systemic Inflammatory Signature in African Americans.
Sutaria N; Alphonse MP; Marani M; Parthasarathy V; Deng J; Wongvibulsin S; Williams K; Roh YS; Choi J; Bordeaux Z; Pritchard T; Dillen C; Semenov YR; Kwatra MM; Archer NK; Garza LA; Dong X; Kang S; Kwatra SG
J Invest Dermatol; 2022 May; 142(5):1300-1308.e3. PubMed ID: 34717952
[TBL] [Abstract][Full Text] [Related]
2. The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: A cluster analysis.
Parthasarathy V; Cravero K; Xu L; Deng J; Sun Z; Engle SM; Sims JT; Okragly AJ; Kwatra SG
J Am Acad Dermatol; 2023 May; 88(5):1101-1109. PubMed ID: 36806647
[TBL] [Abstract][Full Text] [Related]
3. Circulating plasma IL-13 and periostin are dysregulated type 2 inflammatory biomarkers in prurigo nodularis: A cluster analysis.
Parthasarathy V; Cravero K; Deng J; Sun Z; Engle SM; Auxier AN; Hahn N; Sims JT; Okragly AJ; Alphonse MP; Kwatra SG
Front Med (Lausanne); 2022; 9():1011142. PubMed ID: 36561717
[TBL] [Abstract][Full Text] [Related]
4. Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis: A Secondary Analysis of a Randomized Clinical Trial.
Kimel M; Zeidler C; Kwon P; Revicki D; Ständer S
JAMA Dermatol; 2020 Dec; 156(12):1354-1358. PubMed ID: 32936233
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive plasma cytokine and chemokine profiling in prurigo nodularis reveals endotypes in Type 2 inflammation.
Cornman HL; Manjunath J; Reddy SV; Adams J; Rajeh A; Samuel C; Bao A; Zhao R; Ma EZ; Shumsky J; Pritchard TW; Imo BU; Kollhoff AL; Lee KK; Lu W; Yossef S; Kwatra MM; Kwatra SG
Sci Rep; 2024 Apr; 14(1):8098. PubMed ID: 38582943
[TBL] [Abstract][Full Text] [Related]
6. Prurigo nodularis: new insights into pathogenesis and novel therapeutics.
Liao V; Cornman HL; Ma E; Kwatra SG
Br J Dermatol; 2024 May; 190(6):798-810. PubMed ID: 38345154
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis.
Kwatra SG; Rodriguez D; Dias-Barbosa C; Budhiarso I; Fofana F; Vernon M; Gabriel S; Piketty C; Puelles J
Dermatol Ther (Heidelb); 2023 Oct; 13(10):2403-2416. PubMed ID: 37615836
[TBL] [Abstract][Full Text] [Related]
8. The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis.
Janmohamed SR; Gwillim EC; Yousaf M; Patel KR; Silverberg JI
Arch Dermatol Res; 2021 Oct; 313(8):669-677. PubMed ID: 33108524
[TBL] [Abstract][Full Text] [Related]
9. Ethnic differences and comorbidities of 909 prurigo nodularis patients.
Boozalis E; Tang O; Patel S; Semenov YR; Pereira MP; Stander S; Kang S; Kwatra SG
J Am Acad Dermatol; 2018 Oct; 79(4):714-719.e3. PubMed ID: 29733939
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study.
Sofen H; Bissonnette R; Yosipovitch G; Silverberg JI; Tyring S; Loo WJ; Zook M; Lee M; Zou L; Jiang GL; Paolini JF
EClinicalMedicine; 2023 Mar; 57():101826. PubMed ID: 36816342
[TBL] [Abstract][Full Text] [Related]
11. Abnormal Plasma Levels of Steroids and Their Ratios in Patients With Prurigo Nodularis: A Pilot Study.
Chu L; Shu X; Wu Y; Yang H; Lu Q; Deng H
Front Physiol; 2022; 13():835269. PubMed ID: 35837010
[No Abstract] [Full Text] [Related]
12. The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis.
Ständer S; Fofana F; Dias-Barbosa C; Rodriguez D; Budhiarso I; Jabbar-Lopez ZK; Piketty C; Vernon M; Puelles J
Dermatol Ther (Heidelb); 2023 Jul; 13(7):1587-1602. PubMed ID: 37329468
[TBL] [Abstract][Full Text] [Related]
13. Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta.
Hashimoto T; Nattkemper LA; Kim HS; Kursewicz CD; Fowler E; Shah SM; Nanda S; Fayne RA; Paolini JF; Romanelli P; Yosipovitch G
Exp Dermatol; 2021 Jun; 30(6):804-810. PubMed ID: 33428793
[TBL] [Abstract][Full Text] [Related]
14. Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
Husein-ElAhmed H; Steinhoff M
J Dermatolog Treat; 2022 May; 33(3):1547-1553. PubMed ID: 33200955
[TBL] [Abstract][Full Text] [Related]
15. Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances.
Ständer S; Yosipovitch G; Lacour JP; Legat FJ; Paul C; Reich A; Chaouche K; Ahmad F; Piketty C
J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1820-1825. PubMed ID: 35766128
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis.
Nilforoushzadeh MA; Heidari N; Ghane Y; Heidari A; Hajikarim-Hamedani A; Hosseini S; Jaffary F; Najar Nobari M; Tavakolzadeh P; Najar Nobari N
Inflammopharmacology; 2024 Apr; 32(2):991-1003. PubMed ID: 38332383
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis.
Williams KA; Roh YS; Brown I; Sutaria N; Bakhshi P; Choi J; Gabriel S; Chavda R; Kwatra SG
Expert Rev Clin Pharmacol; 2021 Jan; 14(1):67-77. PubMed ID: 33191806
[No Abstract] [Full Text] [Related]
18. Efficacy of dupilumab in prurigo nodularis in elderly patient.
Giura MT; Viola R; Fierro MT; Ribero S; Ortoncelli M
Dermatol Ther; 2020 Jan; 33(1):e13201. PubMed ID: 31856368
[TBL] [Abstract][Full Text] [Related]
19. Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization.
Belzberg M; Alphonse MP; Brown I; Williams KA; Khanna R; Ho B; Wongvibulsin S; Pritchard T; Roh YS; Sutaria N; Choi J; Jedrych J; Johnston AD; Sarkar K; Vasavda C; Meixiong J; Dillen C; Bondesgaard K; Paolini JF; Chen W; Corcoran D; Devos N; Kwatra MM; Chien AL; Archer NK; Garza LA; Dong X; Kang S; Kwatra SG
J Invest Dermatol; 2021 Sep; 141(9):2208-2218.e14. PubMed ID: 33771530
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life and economic burden of prurigo nodularis.
Whang KA; Le TK; Khanna R; Williams KA; Roh YS; Sutaria N; Choi J; Gabriel S; Chavda R; Semenov Y; Kwatra SG
J Am Acad Dermatol; 2022 Mar; 86(3):573-580. PubMed ID: 34058278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
